IDH2 and acute myeloid leukemia: Nevertheless, the frequency of detected mutations by conventional PCR at diagnosis reflect a real world AML cohort (22% NPM1, 17% FLT3-ITD, 5% FLT3-TKD, IDH1 7%, and IDH2 11%) [18].